View Document Preview and Link Document Date: 2014-07-01 00:54:18 Open Document File Size: 186,93 KB Share Result on Facebook
City Tokyo / / Company Welfare Pharmaceuticals / Medical Devices Agency Pharmaceutical / Medical Devices Safety Information / Schizophrenia (hypertension obesity diabetes mellitus extrapyramidal symptom) Pharmaceuticals / Chiyoda / Schizophrenia (hepatitis C hypertension hepatic function abnormal) Pharmaceuticals / PMDA PMDSI Pharmaceuticals / / Continent Asia / Europe / / Country Thailand / Japan / United States / China / Singapore / South Korea / / / Event FDA Phase / / IndustryTerm injection site / medical and pharmaceutical providers / pharmaceuticals / healthcare professionals / administration site / healthcare providers / / MedicalCondition hepatitis C / obesity / disorder / infections / arrhythmia / hypertension / schizophrenia / Psychotropics Schizophrenia PRECAUTIONS / shortness of breath / Psychotropics Schizophrenia / auditory hallucinations / Myocardial infarction / suspected arrhythmia / diabetes mellitus / depression / / Organization Pharmaceutical Affairs and Food Sanitation Council / Subcommittee on Drug Safety / Committee on Drug Safety / Pharmaceuticals and Medical Devices Agency / XEPLION administration / Japan Office / Ministry of Health / Food Safety Bureau / been reported following antipsychotic XEPLION administration / / Person Labour / / Position Minister of Health / / Product midodrine hydrochloride / Therapeutic Category Indications XEPLION Aqueous Suspension / valsartan / XEPLION Aqueous Suspension / Introduction XEPLION Aqueous Suspension / risperidone / clonazepam / triazolam / allopurinol / promethazine hydrochloride / olanzapine / telmisartan / tolterodine / trichlormethiazide / lorazepam / candesartan cilexetil / IM injection / Risperdal Consta / fenofibrate / metformin hydrochloride / atenolol / lithium carbonate / Intramuscular Injection / China / XEPLION / United States / / Technology X-ray / pharmacokinetics / / URL http / SocialTag 
Pharmaceuticals and Medical Devices Safety Information No. 313 May 2014